Two questions, two models
Structure prediction answers "what shape would this sequence take, and does its binding site complement the target?" Binding prediction answers "would this candidate actually bind, and how well?" They are separate because geometry and affinity are separate facts: a well-folded binding site can still fail to bind a given target, and a model that predicts shape well is not automatically good at predicting affinity.
Where predictions get shaky
A prediction model is only as good as the match between its training conditions and the case in front of it. Unusual targets, unusual antibody families, or assay formats the model never saw push the estimate outside the range where it was validated. Treat a prediction as a hypothesis to test, not as a result.